Portfolio Holdings Detail for ISIN IE00BKVL7331
Stock Name / FundiShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMVEA.AS(USD) CXE
ETF TickerMVEA.DE(EUR) CXE
ETF TickerMVEA.LS(GBP) CXE
ETF TickerMVEA(USD) Euronext Amsterdam

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-11 (Tuesday)980USD 968,848LLY holding increased by 21541USD 968,8480USD 21,541 USD 988.62 USD 966.64
2025-11-10 (Monday)980USD 947,307LLY holding increased by 41424USD 947,3070USD 41,424 USD 966.64 USD 924.37
2025-11-07 (Friday)980USD 905,883LLY holding decreased by -12808USD 905,8830USD -12,808 USD 924.37 USD 937.44
2025-11-06 (Thursday)980LLY holding decreased by -60USD 918,691LLY holding decreased by -44151USD 918,691-60USD -44,151 USD 937.44 USD 925.81
2025-11-05 (Wednesday)1,040USD 962,842LLY holding increased by 19708USD 962,8420USD 19,708 USD 925.81 USD 906.86
2025-11-04 (Tuesday)1,040USD 943,134LLY holding increased by 10743USD 943,1340USD 10,743 USD 906.86 USD 896.53
2025-11-03 (Monday)1,040LLY holding decreased by -30USD 932,391LLY holding increased by 9131USD 932,391-30USD 9,131 USD 896.53 USD 862.86
2025-10-31 (Friday)1,070USD 923,260LLY holding increased by 19645USD 923,2600USD 19,645 USD 862.86 USD 844.5
2025-10-30 (Thursday)1,070USD 903,615LLY holding increased by 33138USD 903,6150USD 33,138 USD 844.5 USD 813.53
2025-10-29 (Wednesday)1,070LLY holding decreased by -270USD 870,477LLY holding decreased by -228457USD 870,477-270USD -228,457 USD 813.53 USD 820.1
2025-10-28 (Tuesday)1,340USD 1,098,934LLY holding decreased by -8455USD 1,098,9340USD -8,455 USD 820.1 USD 826.41
2025-10-27 (Monday)1,340USD 1,107,389LLY holding increased by 1286USD 1,107,3890USD 1,286 USD 826.41 USD 825.45
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BKVL7331

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-06SELL-60949.890916.263 919.626EUR -55,178 804.69 Loss of -6,896 on sale
2025-11-03SELL-30901.339862.680 866.546EUR -25,996 803.23 Loss of -1,900 on sale
2025-10-29SELL-270813.530830.290 828.614EUR -223,726 802.70 Loss of -6,996 on sale
2025-10-21BUY60799.570812.990 811.648EUR 48,699 802.27
2025-10-03BUY30839.870848.130 847.304EUR 25,419 801.79
2025-10-02SELL-30819.850834.460 832.999EUR -24,990 801.70 Loss of -939 on sale
2025-09-24SELL-90741.850746.940 746.431EUR -67,179 803.33 Profit of 5,121 on sale
2025-08-29SELL-60732.580737.420 736.936EUR -44,216 805.10 Profit of 4,090 on sale
2025-08-15SELL-30701.230706.790 706.234EUR -21,187 805.66 Profit of 2,983 on sale
2025-07-17BUY19761.500790.000 787.150EUR 14,956 811.07
2025-07-09SELL-29786.920794.000 793.292EUR -23,005 811.82 Profit of 537 on sale
2025-07-07SELL-29772.870781.150 780.322EUR -22,629 812.27 Profit of 926 on sale
2025-06-25SELL-58792.300798.950 798.285EUR -46,301 813.58 Profit of 887 on sale
2025-06-17SELL-58791.240805.160 803.768EUR -46,619 814.98 Profit of 650 on sale
2025-06-16SELL-174807.580825.000 823.258EUR -143,247 815.03 Loss of -1,432 on sale
2025-05-30SELL-1,826737.670745.900 745.077EUR -1,360,511 818.00 Profit of 133,161 on sale
2025-05-20SELL-220747.010763.500 761.851EUR -167,607 823.91 Profit of 13,653 on sale
2025-05-14SELL-55715.560759.500 755.106EUR -41,531 826.59 Profit of 3,931 on sale
2025-05-13SELL-55746.060759.500 758.156EUR -41,699 827.23 Profit of 3,799 on sale
2025-05-06SELL-110775.120818.420 814.090EUR -89,550 830.12 Profit of 1,763 on sale
2025-05-01SELL-55794.100850.930 845.247EUR -46,489 830.56 Loss of -808 on sale
2025-04-28SELL-55877.290882.250 881.754EUR -48,496 829.05 Loss of -2,899 on sale
2025-04-25SELL-165884.540885.580 885.476EUR -146,104 828.56 Loss of -9,391 on sale
2025-04-15BUY55757.180765.310 764.497EUR 42,047 829.73
2025-04-14BUY55754.350759.560 759.039EUR 41,747 830.46
2025-04-10BUY165720.910741.950 739.846EUR 122,075 832.52
2025-04-09BUY55753.710754.830 754.718EUR 41,509 833.30
2025-04-08BUY275726.240763.500 759.774EUR 208,938 834.39
2025-04-07BUY165723.730748.000 745.573EUR 123,020 835.52
2025-03-31BUY330825.910828.010 827.800EUR 273,174 837.16
2025-03-07BUY55869.580908.000 904.158EUR 49,729 838.20
2025-03-04BUY110911.060929.160 927.350EUR 102,008 836.04
2025-02-18SELL-165857.200862.730 862.177EUR -142,259 827.49 Loss of -5,723 on sale
2025-02-14SELL-55844.270873.500 870.577EUR -47,882 826.97 Loss of -2,399 on sale
2025-02-07BUY55878.310889.360 888.255EUR 48,854 823.20
2025-01-31SELL-55811.080827.350 825.723EUR -45,415 822.38 Loss of -184 on sale
2025-01-02SELL-55778.070787.000 786.107EUR -43,236 826.34 Profit of 2,213 on sale
2024-12-06BUY55826.710841.000 839.571EUR 46,176 827.46
2024-12-03SELL-55813.330817.130 816.750EUR -44,921 827.79 Profit of 607 on sale
2024-11-25SELL-1,291755.000755.000 755.000EUR -974,705 838.77 Profit of 108,143 on sale
2024-11-25SELL-1,291755.000755.000 755.000EUR -974,705 838.77 Profit of 108,143 on sale
2024-11-21BUY72749.920753.000 752.692EUR 54,194 844.56
2024-11-19SELL-72729.730730.000 729.973EUR -52,558 851.66 Profit of 8,762 on sale
2024-11-18SELL-72727.200734.000 733.320EUR -52,799 856.11 Profit of 8,841 on sale
2024-11-07SELL-144797.450802.550 802.040EUR -115,494 862.15 Profit of 8,656 on sale
2024-11-06SELL-288776.380820.730 816.295EUR -235,093 865.88 Profit of 14,281 on sale
2024-11-01SELL-216818.930833.000 831.593EUR -179,624 885.47 Profit of 11,638 on sale
2024-11-01SELL-216818.930833.000 831.593EUR -179,624 885.47 Profit of 11,638 on sale
2024-10-31SELL-72829.740853.500 851.124EUR -61,281 892.90 Profit of 3,008 on sale
2024-10-31SELL-72829.740853.500 851.124EUR -61,281 892.90 Profit of 3,008 on sale
2024-10-23SELL-504903.250907.950 907.480EUR -457,370 907.64 Profit of 81 on sale
2024-10-23SELL-504903.250907.950 907.480EUR -457,370 907.64 Profit of 81 on sale
2024-10-22SELL-72909.150911.120 910.923EUR -65,586 906.13 Loss of -345 on sale
2024-10-22SELL-72909.150911.120 910.923EUR -65,586 906.13 Loss of -345 on sale
2024-10-21SELL-144906.130918.860 917.587EUR -132,133 0.00 Loss of -132,133 on sale
2024-10-21SELL-144906.130918.860 917.587EUR -132,133 0.00 Loss of -132,133 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.